Back to search

Article

Estimated Costs of Production Compared with National Prices, for Drugs to Treat Clinical Obesity

2022-04-23

Abstract excerpt

Background: Over 13% of adults are living with obesity globally, three-fold higher than in 1975, and rising. Obesity increases the risks of cardiovascular disease, diabetes, cancer, adverse birth and mental health outcomes, and COVID-19 mortality. Anti-obesity treatments, including new highly effective but expensive injectable agents are needed to supplement lifestyle interventions and surgical options. <br><br>M...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7124c808-4a35-5330-b455-830d54693e5e
DOI
10.2139/ssrn.4068270
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Estimated Costs of Production Compared with National Prices, for Drugs to Treat Clinical ObesityDOI 10.2139/ssrn.4068270
How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent ExpirySemantic proximity
Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsSemantic proximity
Evaluating Diabetes-Specific Meal Replacements for Glycaemic Control in Overweight and Obese T2DM Patients: A Protocol for a Randomized Controlled TrialSemantic proximity
Guiding the willingness to pay for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome using a cost-based-plus pricing frameworkSemantic proximity
Are Semaglutide and Tirzepatide Cost-Effective for Weight Management? A Systematic Review and Meta-analysisSemantic proximity
Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity
Proposal for a Value-Based Agreement to Reimburse Anti-obesity Medicines in Traditional MedicareSemantic proximity
CLINICAL CHARACTERISTICS OF USERS OF WEIGHT LOSS DRUGS: POPULATION-BASED CASE-CONTROL STUDYSemantic proximity
Are quality medicines affordable? Evidence from a large survey of medicine price and quality in IndonesiaSemantic proximity
Current prices versus minimum costs of production for CFTR modulatorsSemantic proximity
Variation in price of cardiovascular and diabetes medicine in Indonesia, and relationship with quality: a mixed methods study in East JavaSemantic proximity
Beyond 'Eat Less and Move More': A Multidimensional Economic Analysis of the Obesity Problem"Semantic proximity
Select a neighboring publication to make it the new centre.